Literature DB >> 8617733

The role of non-catalytic binding subsites in the endonuclease activity of bovine pancreatic ribonuclease A.

M Moussaoui1, A Guasch, E Boix, C Cuchillo, M Nogués.   

Abstract

Bovine pancreatic ribonuclease A catalyzes the depolymerization of RNA. There is much evidence that several subsites, in addition to the main catalytic site, are involved in the formation of the enzyme-substrate complex. This work analyzes the pattern of oligonucleotide formation by ribonuclease A using poly(C) as substrate. The poly(C) cleavage shows that the enzyme does not act in a random fashion but rather prefers the binding and cleavage of the longer substrate molecules and that the phosphodiester bond broken should be 6-7 residues apart from the end of the chain to be preferentially cleaved by ribonuclease A. The results demonstrate the model of the cleavage of an RNA chain based on the cooperative binding between the multisubsite binding structure of ribonuclease A and the phosphates of the polynucleotide (Parés, X., Nogués, M. V., de Llorens, R., and Cuchillo, C. M. (1991) in Essays in Biochemistry (Tipton, K. F., ed) Vol. 26, pp. 89-103, Portland Press Ltd., London). The contribution to the enzymatic process of the non-catalytic phosphate-binding subsite (p2) adjacent to the catalytic center has been analyzed in p2 chemically modified ribonuclease A or by means of site-directed mutagenesis. In both cases deletion of p2 abolishes the endonuclease activity of ribonuclease A, which is substituted by an exonuclease activity. All these results support the role of the multisubsite structure of the enzyme in the endonuclease activity and in the catalytic mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617733     DOI: 10.1074/jbc.271.9.4687

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Binding patterns and kinetics of RNase a interaction with RNA.

Authors:  S Safarian; A A Moosavi-Movahedi
Journal:  J Protein Chem       Date:  2000-07

2.  Pyridoxamine protects proteins from damage by hypohalous acids in vitro and in vivo.

Authors:  Hartman Madu; Josh Avance; Sergei Chetyrkin; Carl Darris; Kristie Lindsey Rose; Otto A Sanchez; Billy Hudson; Paul Voziyan
Journal:  Free Radic Biol Med       Date:  2015-07-06       Impact factor: 7.376

Review 3.  On the failure of de novo-designed peptides as biocatalysts.

Authors:  M J Corey; E Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  A phosphate-binding subsite in bovine pancreatic ribonuclease A can be converted into a very efficient catalytic site.

Authors:  Mohammed Moussaoui; Claudi M Cuchillo; M Victòria Nogués
Journal:  Protein Sci       Date:  2007-01       Impact factor: 6.725

5.  The exo- or endonucleolytic preference of bovine pancreatic ribonuclease A depends on its subsites structure and on the substrate size.

Authors:  Claudi M Cuchillo; Mohamed Moussaoui; Tom Barman; Franck Travers; M Victòria Nogués
Journal:  Protein Sci       Date:  2002-01       Impact factor: 6.725

6.  Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1.

Authors:  Tina T Nguyen; Shih-Chung Chang; Irini Evnouchidou; Ian A York; Christos Zikos; Kenneth L Rock; Alfred L Goldberg; Efstratios Stratikos; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2011-04-10       Impact factor: 15.369

7.  The first crystal structure of human RNase 6 reveals a novel substrate-binding and cleavage site arrangement.

Authors:  Guillem Prats-Ejarque; Javier Arranz-Trullén; Jose A Blanco; David Pulido; M Victòria Nogués; Mohammed Moussaoui; Ester Boix
Journal:  Biochem J       Date:  2016-03-24       Impact factor: 3.857

8.  Molecular evolution of B6 enzymes: binding of pyridoxal-5'-phosphate and Lys41Arg substitution turn ribonuclease A into a model B6 protoenzyme.

Authors:  Rosa A Vacca; Sergio Giannattasio; Guido Capitani; Ersilia Marra; Philipp Christen
Journal:  BMC Biochem       Date:  2008-06-19       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.